KELLY JACKSON: Open Payments
NPI 1033653431 · HUNTINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,055 in 47 payments from 12 companies in 2025. Trend: 2023 $1,292 · 2024 $2,036 · 2025 $1,055
Food & beverage: $946Education: $109
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $206 |
| Janssen Biotech, Inc. | 4 | $188 |
| ABBVIE INC. | 10 | $156 |
| GENZYME CORPORATION | 7 | $137 |
| Lilly USA, LLC | 5 | $99 |
| UCB, Inc. | 2 | $69 |
| Regeneron Healthcare Solutions, Inc. | 3 | $50 |
| Galderma Laboratories, L.P. | 2 | $41 |
| PFIZER INC. | 2 | $35 |
| Amgen Inc. | 1 | $26 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, TALTZ, Bimzelx, NEMLUVIO, Rhapsido, CIBINQO.
Industry payments across TX — which companies pay providers there.
